A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

March 20, 2015

Primary Completion Date

August 26, 2016

Study Completion Date

August 26, 2016

Conditions
Acne Vulgaris
Interventions
DRUG

Sarecycline

Administered based on participant's body weight.

Trial Locations (56)

10016

Actavis Investigational Study Site #146, New York

10155

Actavis Investigational Study Site #208, New York

11790

Actavis Investigational Study Site #230, Stony Brook

14623

Actavis Investigational Study Site #240, Rochester

19103

Actavis Investigational Study Site #257, Philadelphia

20850

Actavis Investigational Study Site #217, Rockville

23507

Actavis Investigational Study Site #244, Norfolk

27612

Actavis Investigational Study Site #229, Raleigh

30078

Actavis Investigational Study Site #242, Snellville

32073

Actavis Investigational Study Site #151, Orange

33142

Actavis Investigational Study Site #249, Miami

33162

Actavis Investigation Study Site # 140, North Miami Beach

33175

Actavis Investigational Study Site #145, Miami

33207

Actavis Investigational Study Site #211, Miramar

33458

Actavis Investigational Study Site #238, Jupiter

33609

Actavis Investigational Study Site #203, Tampa

33761

Actavis Investigational Study Site #226, Clearwater

36608

Actavis Investigational Study Site #206, Mobile

37072

Actavis Investigational Study Site #225, Goodlettsville

37215

Actavis Investigational Study Site #109, Nashville

37917

Actavis Investigational Study Site #128, Knoxville

37922

Actavis Investigational Study Site #216, Knoxville

40202

Actavis Investigational Study Site #213, Louisville

46617

Actavis Investigational Study Site #113, South Bend

48038

Actavis Investigational Study Site #235, Clinton Township

48059

Actavis Investigational Study Site #227, Fort Gratiot

48088

Actavis Investigational Study Site #111, Warren

48346

Actavis Investigational Study Site #251, Clarkston

55432

Actavis Investigational Study Site #221, Fridley

60611

Actavis Investigational Study Site #106, Chicago

68144

Actavis Investigational Study Site #231, Omaha

71913

Actavis Investigational Study Site #236, Hot Springs

75093

Actavis Investigational Study Site #101, Plano

75234

Actavis Investigational Study Site #104, Dallas

76011

Actavis Investigational Study Site #223, Arlington

Actavis Investigational Study Site #252, Arlington

77004

Actavis Investigational Study Site #142, Houston

77056

Actavis Investigational Study Site #105, Houston

77494

Actavis Investigational Study Site #201, Katy

77845

Actavis Investigational Study Site #220, College Station

78218

Actavis Investigational Study Site #207, San Antonio

78660

Actavis Investigational Study Site #223, Pflugerville

80033

Actavis Investigational Study Site #148, Wheat Ridge

80220

Actavis Investigational Study Site #222, Denver

83704

Actavis Investigational Study Site #124, Boise

84088

Actavis Investigational Study Site #212, West Jordan

91436

Actavis Investigational Study Site #129, Encino

92008

Actavis Investigational Study Site #245, Carlsbad

92120

Actavis Investigational Study Site #150, San Diego

92123

Actavis Investigational Study Site #125, San Diego

Actavis Investigational Study Site #204, San Diego

94538

Actavis Investigational Study Site #209, Fremont

95819

Actavis Investigational Study Site #147, Sacramento

97030

Actavis Investigational Study Site #149, Gresham

99202

Actavis Investigational Study Site #144, Spokane

99362

Actavis Investigational Study Site #233, Walla Walla

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Almirall, S.A.

INDUSTRY